Metformin Promotes Angiogenesis in Neonatal Lung Injury: A New Deal of an Old Drug
Am J Respir Cell Mol Biol
.
2024 Oct;71(4):386-387.
doi: 10.1165/rcmb.2024-0202ED.
Authors
Phyllis A Dennery
1
2
,
Hongwei Yao
1
3
4
Affiliations
1
Department of Molecular Biology, Cell Biology & Biochemistry Brown University Providence, Rhode Island.
2
Department of Pediatrics Warren Alpert Medical School of Brown University Providence, Rhode Island.
3
Department of Medicine Warren Alpert Medical School of Brown University Providence, Rhode Island.
4
Providence Veterans Affairs Medical Center Providence, Rhode Island.
PMID:
38923887
PMCID:
PMC11450311
DOI:
10.1165/rcmb.2024-0202ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Angiogenesis
Animals
Animals, Newborn
Humans
Infant, Newborn
Lung Injury / drug therapy
Metformin* / pharmacology
Metformin* / therapeutic use
Neovascularization, Physiologic / drug effects
Substances
Metformin
Grants and funding
P30 GM149398/GM/NIGMS NIH HHS/United States
R01 HL166327/HL/NHLBI NIH HHS/United States
R01HL166327/HL/NHLBI NIH HHS/United States
P30GM149398/GM/NIGMS NIH HHS/United States